Trial intelligence / Profile preview

Remimazolam vs propofol for anesthesia induction in painless abortion

ChiCTR2300075375Phase 4Recruiting

Sponsor
Ningbo Zhenhai District Traditional Chinese Medicine Hospital
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by Ningbo Zhenhai District Traditional Chinese Medicine Hospital. Primary endpoint: Time between the end of general anesthesia and the first eye opening. Started Sep 2023; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2300075375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300075375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call